Treatment Patterns and Long-term Outcomes with Anti–VEGF Therapy for Retinal Vein Occlusion
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Authors
- Sharon Fekrat (ORCID: https://orcid.org/0000-0003-4403-5996)
- Kara Gibson (ORCID: https://orcid.org/0009-0001-9016-3481)
- Michael S. Ip (ORCID: https://orcid.org/0000-0003-1304-4101)
- Nick Boucher (ORCID: https://orcid.org/0000-0002-3657-575X)
- Liliana P Paris (ORCID: https://orcid.org/0000-0002-9312-9924)
- Pablo Arrisi
- Fabio Ishii
- Matthew Fenech (ORCID: https://orcid.org/0000-0001-7933-4617)
- C. Gloria (ORCID: https://orcid.org/0000-0001-5657-5979)
- Yasha S. Modi
- Ying Liu (ORCID: https://orcid.org/0000-0001-7035-5542)
Institutions
- University of Liverpool (GB)
- Duke University (US)
- Royal Liverpool University Hospital (GB)
- NYU Langone Health (US)
- Doheny Eye Institute (US)
- Roche (United Kingdom) (GB)
Publication Details
- Journal
- Ophthalmology Retina
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1016/j.oret.2025.05.025
- Citations
- 5
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.54
Funders
- F. Hoffmann-La Roche